Bancorp. of Southern Indiana (BCSO)
USD 47.0
(0.0%)
USD 47.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.7 Million | 7.62 Million | 9.47 Million | -1.55 Million | 5.53 Million | 4.31 Million |
| Net Income | 6.81 Million | 7.25 Million | 8.87 Million | 6.95 Million | 5.53 Million | 4.31 Million |
| Depreciation & Amortization | 1.22 Million | 1.03 Million | 1.63 Million | 1.43 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 489 Thousand | -645 Thousand | -2.36 Million | -2.14 Million | - | - |
| Other non-cash items | 3.63 Million | 2.05 Million | -2.54 Million | -3.16 Million | -5.53 Million | -4.31 Million |
| Investing Cash Flow | -145.67 Million | -136.57 Million | -23.89 Million | -69.45 Million | - | - |
| Investments in PPE | -9.22 Million | -3.37 Million | -1.9 Million | -1.57 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -11.74 Million | -52.42 Million | -56.84 Million | -29.46 Million | - | - |
| Sales/Maturities of investments | 20.12 Million | 20.47 Million | 31.79 Million | 25.3 Million | - | - |
| Other Investing Activities | -3.02 Million | -4.23 Million | 1.9 Million | 2.62 Million | - | - |
| Financing Cash Flow | 123.05 Million | 40 Million | 69.7 Million | 105.51 Million | - | - |
| Debt repayment | -73.11 Million | -5.74 Million | -7.41 Million | -2.86 Million | - | - |
| Dividends payments | -2.12 Million | -2.12 Million | -2.1 Million | -1.9 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -249 Thousand | - | - | - | - |
| Other Financing Activities | 52.06 Million | -249 Thousand | 79.22 Million | 110.28 Million | - | - |
| Accounts receivables | -894 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.38 Million | - | - | - | - | - |
| Cash at beginning of period | 29.23 Million | 118.18 Million | 62.89 Million | 28.39 Million | - | - |
| Cash at end of period | 16.31 Million | 29.23 Million | 118.18 Million | 62.89 Million | 5.53 Million | 4.31 Million |
| Capital Expenditure | -9.22 Million | -3.37 Million | -1.9 Million | -1.57 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.92 Million | -88.95 Million | 55.28 Million | 34.5 Million | 5.53 Million | 4.31 Million |
| Free Cash Flow | 477 Thousand | 4.24 Million | 7.57 Million | -3.13 Million | 5.53 Million | 4.31 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.81 Million | 6.68 Million | 6.56 Million | 6.61 Million | 7.25 Million | 6.41 Million |
| Depreciation & Amortization | 1.22 Million | - | - | - | 1.03 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 489 Thousand | - | - | - | -645 Thousand | - |
| Other non-cash items | 3.63 Million | -6.68 Million | -6.56 Million | -6.61 Million | 2.05 Million | -6.41 Million |
| Investing Cash Flow | -145.67 Million | - | - | - | -136.57 Million | - |
| Investments in PPE | -9.22 Million | - | - | - | -3.37 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -11.74 Million | - | - | - | -52.42 Million | - |
| Sales/Maturities of investments | 20.12 Million | - | - | - | 20.47 Million | - |
| Other Investing Activities | -3.02 Million | - | - | - | -4.23 Million | - |
| Financing Cash Flow | 123.05 Million | - | - | - | 40 Million | - |
| Debt repayment | -73.11 Million | - | - | - | -5.74 Million | - |
| Dividends payments | -2.12 Million | - | - | - | -2.12 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | -249 Thousand | - |
| Other Financing Activities | 52.06 Million | - | - | - | -249 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 29.23 Million | - | - | - | 118.18 Million | - |
| Cash at end of period | 16.31 Million | 6.68 Million | 6.56 Million | 6.61 Million | 29.23 Million | 6.41 Million |
| Capital Expenditure | -9.22 Million | - | - | - | -3.37 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.92 Million | 6.68 Million | 6.56 Million | 6.61 Million | -88.95 Million | 6.41 Million |
| Free Cash Flow | 477 Thousand | 6.68 Million | 6.56 Million | 6.61 Million | 4.24 Million | 6.41 Million |
3311
BORORENEW
BIOTEC
GHCL
1512
1009